1 completed, 1 terminated. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 1, Terminated 1 |
Follow ancestim: new trials by email Literature Review of ancestim trials Research Report on ancestim
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Stem Cell Factor (SCF) Priming of Haematopoietic Stem Cell Grafts in Malignant Lymphoma r-metHuSCF and Filgrastim, Chemotherapy plus Filgrastim - Malignant Lymphoma | Phase 2 | Terminated | Aalborg University Hospital | 32 | 1999-01-01 | 2015-06-25 |
| Comparing Treatments for Multiple Myeloma Stemgen - Multiple Myeloma | Phase 2 | Completed | National Heart, Lung, and Blood Institute (NHLBI) | 32 | 1998-09-01 | 2008-03-04 |
Lymphoma (1) · Multiple Myeloma (1)
Aalborg University Hospital (1) · National Heart, Lung, and Blood Institute (NHLBI) (1)
Denmark (1) · Finland (1) · Norway (1) · Sweden (1) · United States (1)